Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery

Alex F.Y. Chen, Timothy O'Brien, Masato Tsutsui, Hiroyuki Kinoshita, Vincent J. Pompili, Thomas B. Crotty, David J. Spector, Zvonimir S. Katusic

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Endothelial NO synthase (eNOS) is an enzyme responsible for the production of a potent vasodilator and a key regulator of vascular tone, NO. In peripheral arteries, expression of a recombinant eNOS gene increases production of NO in the blood vessel wall. This approach appears to be a promising strategy for gene therapy of cerebrovascular disease. The major objective of the present study was to determine whether a recombinant eNOS gene (AdCMVNOS) can be functionally expressed in cerebral arteries. Replication-defective recombinant adenovirus vectors encoding bovine eNOS and Escherichia colt β-galactosidase (AdCMVLacZ) genes, driven by the cytomegalovirus promoter, were used for ex vivo gene transfer. Rings of canine basilar artery were incubated with increasing titers of the vectors in MEM. Twenty-four or forty-eight hours after gene transfer, expression and function of AdCMVNOS were evaluated by (1) immunohistochemical staining, (2) isometric tension recording, and (3) cGMP radioimmunoassay. Transfection with AdCMVNOS resulted in the expression of recombinant eNOS protein in the vascular adventitia and endothelium, associated with significantly reduced contractile responses to UTP and enhanced endothelium-dependent relaxation to calcium ionophore A23187. Basal production of cGMP was significantly increased in the transfected vessels. The reduced contractions to UTP with increased cGMP production were reversed by a NOS inhibitor, N(G)-monomethyl- L-arginine. Contractions to UTP or production of cGMP were not affected in arteries transfected with AdCMVLacZ reporter gene. The results of the present study represent the first successful transfer and functional expression of recombinant eNOS gene in cerebral arteries. Our findings suggest that cerebral arterial tone can be modulated by recombinant eNOS expression in the vessel wall.

Original languageEnglish (US)
Pages (from-to)327-335
Number of pages9
JournalCirculation Research
Volume80
Issue number3
DOIs
StatePublished - Jan 1 1997

Fingerprint

Basilar Artery
Nitric Oxide Synthase Type III
Nitric Oxide Synthase
Canidae
Uridine Triphosphate
Genes
Cerebral Arteries
Blood Vessels
Arteries
Galactosidases
Cerebrovascular Disorders
Escherichia
Adventitia
Calcium Ionophores
Vascular Endothelium
Calcimycin
Cytomegalovirus
Vasodilator Agents
Reporter Genes
Adenoviridae

Keywords

  • adenovirus vector
  • cerebral artery
  • gene therapy
  • nitric oxide synthase

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Chen, A. F. Y., O'Brien, T., Tsutsui, M., Kinoshita, H., Pompili, V. J., Crotty, T. B., ... Katusic, Z. S. (1997). Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. Circulation Research, 80(3), 327-335. https://doi.org/10.1161/01.RES.80.3.327

Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. / Chen, Alex F.Y.; O'Brien, Timothy; Tsutsui, Masato; Kinoshita, Hiroyuki; Pompili, Vincent J.; Crotty, Thomas B.; Spector, David J.; Katusic, Zvonimir S.

In: Circulation Research, Vol. 80, No. 3, 01.01.1997, p. 327-335.

Research output: Contribution to journalArticle

Chen, AFY, O'Brien, T, Tsutsui, M, Kinoshita, H, Pompili, VJ, Crotty, TB, Spector, DJ & Katusic, ZS 1997, 'Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery', Circulation Research, vol. 80, no. 3, pp. 327-335. https://doi.org/10.1161/01.RES.80.3.327
Chen, Alex F.Y. ; O'Brien, Timothy ; Tsutsui, Masato ; Kinoshita, Hiroyuki ; Pompili, Vincent J. ; Crotty, Thomas B. ; Spector, David J. ; Katusic, Zvonimir S. / Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. In: Circulation Research. 1997 ; Vol. 80, No. 3. pp. 327-335.
@article{749c80b9ad614ccd949b065e527ada4b,
title = "Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery",
abstract = "Endothelial NO synthase (eNOS) is an enzyme responsible for the production of a potent vasodilator and a key regulator of vascular tone, NO. In peripheral arteries, expression of a recombinant eNOS gene increases production of NO in the blood vessel wall. This approach appears to be a promising strategy for gene therapy of cerebrovascular disease. The major objective of the present study was to determine whether a recombinant eNOS gene (AdCMVNOS) can be functionally expressed in cerebral arteries. Replication-defective recombinant adenovirus vectors encoding bovine eNOS and Escherichia colt β-galactosidase (AdCMVLacZ) genes, driven by the cytomegalovirus promoter, were used for ex vivo gene transfer. Rings of canine basilar artery were incubated with increasing titers of the vectors in MEM. Twenty-four or forty-eight hours after gene transfer, expression and function of AdCMVNOS were evaluated by (1) immunohistochemical staining, (2) isometric tension recording, and (3) cGMP radioimmunoassay. Transfection with AdCMVNOS resulted in the expression of recombinant eNOS protein in the vascular adventitia and endothelium, associated with significantly reduced contractile responses to UTP and enhanced endothelium-dependent relaxation to calcium ionophore A23187. Basal production of cGMP was significantly increased in the transfected vessels. The reduced contractions to UTP with increased cGMP production were reversed by a NOS inhibitor, N(G)-monomethyl- L-arginine. Contractions to UTP or production of cGMP were not affected in arteries transfected with AdCMVLacZ reporter gene. The results of the present study represent the first successful transfer and functional expression of recombinant eNOS gene in cerebral arteries. Our findings suggest that cerebral arterial tone can be modulated by recombinant eNOS expression in the vessel wall.",
keywords = "adenovirus vector, cerebral artery, gene therapy, nitric oxide synthase",
author = "Chen, {Alex F.Y.} and Timothy O'Brien and Masato Tsutsui and Hiroyuki Kinoshita and Pompili, {Vincent J.} and Crotty, {Thomas B.} and Spector, {David J.} and Katusic, {Zvonimir S.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1161/01.RES.80.3.327",
language = "English (US)",
volume = "80",
pages = "327--335",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery

AU - Chen, Alex F.Y.

AU - O'Brien, Timothy

AU - Tsutsui, Masato

AU - Kinoshita, Hiroyuki

AU - Pompili, Vincent J.

AU - Crotty, Thomas B.

AU - Spector, David J.

AU - Katusic, Zvonimir S.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Endothelial NO synthase (eNOS) is an enzyme responsible for the production of a potent vasodilator and a key regulator of vascular tone, NO. In peripheral arteries, expression of a recombinant eNOS gene increases production of NO in the blood vessel wall. This approach appears to be a promising strategy for gene therapy of cerebrovascular disease. The major objective of the present study was to determine whether a recombinant eNOS gene (AdCMVNOS) can be functionally expressed in cerebral arteries. Replication-defective recombinant adenovirus vectors encoding bovine eNOS and Escherichia colt β-galactosidase (AdCMVLacZ) genes, driven by the cytomegalovirus promoter, were used for ex vivo gene transfer. Rings of canine basilar artery were incubated with increasing titers of the vectors in MEM. Twenty-four or forty-eight hours after gene transfer, expression and function of AdCMVNOS were evaluated by (1) immunohistochemical staining, (2) isometric tension recording, and (3) cGMP radioimmunoassay. Transfection with AdCMVNOS resulted in the expression of recombinant eNOS protein in the vascular adventitia and endothelium, associated with significantly reduced contractile responses to UTP and enhanced endothelium-dependent relaxation to calcium ionophore A23187. Basal production of cGMP was significantly increased in the transfected vessels. The reduced contractions to UTP with increased cGMP production were reversed by a NOS inhibitor, N(G)-monomethyl- L-arginine. Contractions to UTP or production of cGMP were not affected in arteries transfected with AdCMVLacZ reporter gene. The results of the present study represent the first successful transfer and functional expression of recombinant eNOS gene in cerebral arteries. Our findings suggest that cerebral arterial tone can be modulated by recombinant eNOS expression in the vessel wall.

AB - Endothelial NO synthase (eNOS) is an enzyme responsible for the production of a potent vasodilator and a key regulator of vascular tone, NO. In peripheral arteries, expression of a recombinant eNOS gene increases production of NO in the blood vessel wall. This approach appears to be a promising strategy for gene therapy of cerebrovascular disease. The major objective of the present study was to determine whether a recombinant eNOS gene (AdCMVNOS) can be functionally expressed in cerebral arteries. Replication-defective recombinant adenovirus vectors encoding bovine eNOS and Escherichia colt β-galactosidase (AdCMVLacZ) genes, driven by the cytomegalovirus promoter, were used for ex vivo gene transfer. Rings of canine basilar artery were incubated with increasing titers of the vectors in MEM. Twenty-four or forty-eight hours after gene transfer, expression and function of AdCMVNOS were evaluated by (1) immunohistochemical staining, (2) isometric tension recording, and (3) cGMP radioimmunoassay. Transfection with AdCMVNOS resulted in the expression of recombinant eNOS protein in the vascular adventitia and endothelium, associated with significantly reduced contractile responses to UTP and enhanced endothelium-dependent relaxation to calcium ionophore A23187. Basal production of cGMP was significantly increased in the transfected vessels. The reduced contractions to UTP with increased cGMP production were reversed by a NOS inhibitor, N(G)-monomethyl- L-arginine. Contractions to UTP or production of cGMP were not affected in arteries transfected with AdCMVLacZ reporter gene. The results of the present study represent the first successful transfer and functional expression of recombinant eNOS gene in cerebral arteries. Our findings suggest that cerebral arterial tone can be modulated by recombinant eNOS expression in the vessel wall.

KW - adenovirus vector

KW - cerebral artery

KW - gene therapy

KW - nitric oxide synthase

UR - http://www.scopus.com/inward/record.url?scp=0031059375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031059375&partnerID=8YFLogxK

U2 - 10.1161/01.RES.80.3.327

DO - 10.1161/01.RES.80.3.327

M3 - Article

C2 - 9048652

AN - SCOPUS:0031059375

VL - 80

SP - 327

EP - 335

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 3

ER -